KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bionano Genomics (BNGO) Tax Provisions (2017 - 2025)

Bionano Genomics' Tax Provisions history spans 7 years, with the latest figure at $14000.0 for Q3 2025.

  • For Q3 2025, Tax Provisions fell 41.67% year-over-year to $14000.0; the TTM value through Sep 2025 reached $33000.0, up 925.0%, while the annual FY2024 figure was $33000.0, 46.77% down from the prior year.
  • Tax Provisions for Q3 2025 was $14000.0 at Bionano Genomics, up from $11000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $1.8 million in Q4 2022 and bottomed at -$5.8 million in Q4 2021.
  • The 5-year median for Tax Provisions is $14000.0 (2025), against an average of -$195105.3.
  • The largest annual shift saw Tax Provisions crashed 52327.27% in 2021 before it surged 355.56% in 2022.
  • A 5-year view of Tax Provisions shows it stood at -$5.8 million in 2021, then soared by 131.3% to $1.8 million in 2022, then tumbled by 101.99% to -$36000.0 in 2023, then soared by 102.78% to $1000.0 in 2024, then skyrocketed by 1300.0% to $14000.0 in 2025.
  • Per Business Quant, the three most recent readings for BNGO's Tax Provisions are $14000.0 (Q3 2025), $11000.0 (Q2 2025), and $7000.0 (Q1 2025).